Clinical Trials Logo
  1. Home
  2. Infectious Mononucleosis
  3. NCT02715037

Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis

Infectious Mononucleosis Clinical Trial

Official title:
Mikrobiologi Ved svær Akut Tonsillit, peritonsillær Phlegmone og infektiøs Mononukleose

Clinical Trial Summary

Prospective, observational study of the microbiology of patients referred to a tertiary care center with severe acute tonsillitis, peritonsillar cellulitis, or infectious mononucleosis.

Clinical Trial Description

Patients referred to tertiary care centers with acute throat infections are most often treated with antibiotics. However, very little is know concerning the prevalent pathogens in patients with acute throat infections without abscess formation. Evidence suggests that Fusobacterium necrophorum plays an important role in complications of acute tonsillitis (e.g. peritonsillar abscess), but also uncomplicated acute tonsillitis.

This study aims to explore the throat microbiology of patients with severe acute tonsillitis, peritonsillar cellulitis, or infectious mononucleosis with a special attention to a possible role of Fusobacterium necrophorum. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02715037
Study type Observational
Source Aarhus University Hospital
Contact
Status Not yet recruiting
Phase N/A
Start date June 2016
Completion date December 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05683834 - Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons Phase 1/Phase 2
Completed NCT00575185 - Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection Phase 1/Phase 2
Active, not recruiting NCT04645147 - Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection Phase 1
Completed NCT06002802 - Study on Infectious Mononucleosis in Munich
Withdrawn NCT04138875 - A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) Phase 2
Terminated NCT00598988 - Acupuncture for Infectious Mononucleosis Trial Phase 2/Phase 3
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care
Completed NCT00274404 - Controlled Trial of Valacyclovir in Infectious Mononucleosis Phase 1/Phase 2
Terminated NCT02463669 - The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department